GRIN2B and systemic lupus erythematosus: As shown in Figure 5C, Grin2b was found to be involved in seven pathways, such as long-term potentiation, glutamatergic synapse, amphetamine addiction, neuroactive ligand–receptor interaction, systemic lupus erythematosus, circadian entrainment, and dopaminergic synapse.